Millendo Therapeutics Inc

NASDAQ:MLND   1:51:33 PM EDT
2.26
-0.01 (-0.44%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Millendo Therapeutics, Inc. Stock, NASDAQ:MLND

110 Miller Avenue, Suite 100, Ann Arbor, Michigan 48104
United States of America
Phone: +1.734.845.9000
Number of Employees: 38

Description

Millendo Therapeutics, Inc. engages in the development of treatments for orphan endocrine diseases. Its product pipeline includes Livoletide (AZP-531) for the treatment of Prader-Willi syndrome; Nevanimibe for classic congenital adrenal hyperplasia; and Neurokinin 3 receptor for vasomotor symptoms. The company was founded by Julia C. Owens in January 2012 and is headquartered in Ann Arbor, MI.